openPR Logo
Press release

2021 Genotyping Assay Market Report-Increasing Demand for Genome Analysis in Plant and Animal Livestock

07-01-2021 03:45 PM CET | Health & Medicine

Press release from: ReportsnReports

Genotyping Assay Market Report analysis 2021-2027 presents a complete assessment of the market and comprises future trends, current growth factors, attentive opinions, facts, historical information, and forecasts. This Genotyping Assay Market is defined with its related details such as product types, business overview, sales, manufacturers, applications, and other specifications. It provides a systematic approach to the current and prospective scenario of the global regions. Detailed information of the Genotyping Assay Market Report growth rate, technological innovations, and key strategies implemented by the main leading industry players.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=399299

Top Company Profile Analysis in this Report-
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Roche Diagnostics Limited
Qiagen N.V.
Danaher Corporation
Agilent Technologies, Inc.
Fluidigm Corporation
GE Healthcare
Genewiz, Inc.
Integrated Dna Technologies, Inc. (A Subsidiary of Danaher Corporation)
Perkinelmer, Inc.
Bio-Rad Laboratories, Inc.
Eurofins Scientific
Pacific Biosciences of California, Inc.

The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period.

North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases &the spread of infectious and microbial diseases in APAC countries. The increasing outsourcing of clinical research and trials by pharmaceutical and biopharmaceutical companies to organizations in the APAC has driven the demand for genotyping products for drug profile assessment, drug efficacy, safety assessment, dosing determination, and drug response evaluation.

The report analyzes the market for various genotyping products and their adoption pattern. It aims at estimating the market size and future growth potential of the global genotyping market and different segments such as products, technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=399299

Reasons to Buy the Report-
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:-
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global genotyping market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global genotyping market
Market Development: Comprehensive information on the lucrative emerging regions by product, technology, application, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global genotyping market
Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global genotyping market.

Table of Contents in this Report-
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Market Segmentation, By Region
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Genotyping Market Overview
4.2 Asia Pacific: Genotyping Market, By Product & Service, By Country, 2017
4.3 Geographic Snapshot of the Genotyping Market
4.4 Geographic Mix: Genotyping Market
4.5 Genotyping Market: Developing vs Developed Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics: Impact Analysis
5.3 Market Drivers
5.3.1 Technological Advancements and Decreasing Prices of Dna Sequencing
5.3.2 Increasing Incidence of Genetic Diseases and Rising Awareness on Personalized Medicine
5.3.3 Growing Importance of Genotyping in Drug Development
5.3.4 Increasing Demand for Bioinformatics Solutions in Data Analysis
5.4 Market Restraints
5.4.1 High Cost of Equipment Used in Genotyping
5.5 Market Opportunities
5.5.1 Growing Importance of Sequencing Projects
5.5.2 Increasing Application Areas of Genotyping
5.5.3 Increasing Demand for Genome Analysis in Plant and Animal Livestock
5.6 Market Challenges
5.6.1 Data Management in Genotyping Research
5.6.2 Dearth of Trained Resources

6 Industry Insights
6.1 Industry Trends
6.1.1 Increasing Demand for Genotyping & Sequencing Services
6.1.2 Increasing Collaborations
6.1.3 Increasing Awareness
6.2 Regulatory Analysis
6.2.1 Us
6.2.2 Europe
6.2.3 Japan
6.2.4 China
6.2.5 India
6.3 Strategic Benchmarking
6.3.1 Genotyping Market: Product Portfolio Analysis (Instruments & Kits)
6.3.2 Genotyping Market: Product Portfolio Analysis (Bioinformatics)

7 Genotyping Market, By Product & Service
and more...

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2021 Genotyping Assay Market Report-Increasing Demand for Genome Analysis in Plant and Animal Livestock here

News-ID: 2319190 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Genotyping

Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Genotyping Assay Market Size Growth Forecast: What to Expect by 2025? In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Genotyping Market Size By 2025? The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market? The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers
Genotyping Assay Market worth $37.1 billion by 2029
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US) The global genotyping assay market [https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr], valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by
Genotyping Market Outlook and Major Regions' Development Status
The Genotyping Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Genotyping Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001166?utm_source=OpenPR&utm_medium=10791 Key Players Analysis: Hoffmann-La Roche Ltd. Integrated DNA Technologies, Inc. QIAGEN MERCK KGaA Eurofins Genomics Thermo Fisher Scientific Inc BioTek Instruments, Inc. Xcelris Genomics TrimGen Corporation Illumina, Inc. The report covers key developments in the Genotyping
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers